Tumor infiltrating lymphocyte (TIL) therapy represents a promising approach for the treatment of patients whose disease does not benefit from conventional immunotherapies. ...

Radiation can be used as a vaccine, to increase the effect of immunotherapy. We call this Radvax, which is promising. Even in melanoma patients who failed anti-PD-1 treatme...